GSK Stockmann

GSK Stockmann advises national and international (listed) companies from the high-tech, healthcare, finance, real estate and industrial sectors on small-cap M&A, including insolvency-related transactions, divestitures and joint ventures. Through its cooperation with the London office, the group increasingly acts in cross-border matters, particularly for financial investors. Michael Stobbe (focus on M&A in the automotive sector) and Max Wilmanns (M&A, PE and VC in the healthcare and real estate sectors) jointly lead the team, which was strengthened by the arrival of Robert Korndörfer in November 2023 from Noerr and Daniel Fehling, who joined from Luther Rechtsanwaltsgesellschaft mbH in January 2024; both additions boosted not only the practice's M&A, but also PE, VC and corporate capabilities.